This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3
Clinical Decision Support Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
Example realization of the KDN5 PlanDefinition example
{ "resourceType": "RequestGroup", "id": "kdn5-example", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Administer gemcitabine and carboplatin.</div>" }, "contained": [ { "resourceType": "MedicationRequest", "id": "1111", "intent": "proposal", "medicationCodeableConcept": { "coding": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "code": "12574", "display": "gemcitabine" } ], "text": "gemcitabine" }, "subject": { "reference": "Patient/example" }, "dosageInstruction": [ { "text": "1250 mg/m² IV over 30 minutes", "timing": { "repeat": { "duration": 30, "durationUnit": "min" } }, "route": { "text": "IV" }, "doseQuantity": { "value": 1250, "unit": "mg/m²" } } ] }, { "resourceType": "MedicationRequest", "id": "2222", "intent": "proposal", "medicationCodeableConcept": { "coding": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "code": "40048", "display": "Carboplatin" } ], "text": "CARBOplatin" }, "subject": { "reference": "Patient/example" }, "dosageInstruction": [ { "text": "AUC 5 IV over 30 minutes", "timing": { "repeat": { "duration": 30, "durationUnit": "min" } }, "route": { "text": "IV" }, "doseQuantity": { "extension": [ { "url": "http://example.org/fhir/AUC-dose", "valueInteger": 5 } ] } } ] } ], "identifier": [ { "value": "requestgroup-kdn5" } ], "definition": [ { "reference": "PlanDefinition/KDN5" } ], "status": "draft", "intent": "plan", "priority": "routine", "subject": { "reference": "Patient/example" }, "context": { "reference": "Encounter/example" }, "authoredOn": "2017-03-06T17:31:00Z", "author": { "reference": "Practitioner/1" }, "action": [ { "selectionBehavior": "exactly-one", "action": [ { "selectionBehavior": "all", "action": [ { "groupingBehavior": "sentence-group", "selectionBehavior": "exactly-one", "action": [ { "id": "cycle-definition-1", "textEquivalent": "21-day cycle for 6 cycles", "timingTiming": { "repeat": { "count": 6, "duration": 21, "durationUnit": "d" } }, "action": [ { "id": "action-1", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle", "extension": [ { "url": "day", "valueInteger": 1 }, { "url": "day", "valueInteger": 8 } ] } ], "textEquivalent": "Gemcitabine 1250 mg/m² IV over 30 minutes on days 1 and 8", "resource": { "reference": "#1111" } }, { "id": "action-2", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle", "extension": [ { "url": "day", "valueInteger": 1 } ] } ], "textEquivalent": "CARBOplatin AUC 5 IV over 30 minutes on Day 1", "relatedAction": [ { "actionId": "action-1", "relationship": "concurrent-with-start" } ], "resource": { "reference": "#2222" } } ] } ] } ] } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.